Agios Pharmaceuticals (AGIO) shares rallied 5.2% in the last trading session to close at $24.02. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 1.3% gain over the past four weeks. Share price rose after management reported encouraging results from a late-stage study, evaluating orally- administered mitapivat in non-transfusion-dependent (NTD) thalassemia patients. Patients treated with mitapivat achieved dem ...